Geinoz, Sandrine External Entity

Publications

Sort by

Selected publications

  • Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).  Neuro-Oncology2015 Academic Article GET IT
    Times cited: 13

Other